Thromboelastography-Guided Anticoagulant Therapy for the Double Hazard of Thrombohemorrhagic Events in COVID-19: A Report of 3 Cases

Connor M. Bunch; Anthony V. Thomas; John E. Stillson; Laura Gillespie; Kevin P. Lin; Jacob Speybroeck; Hau C. Kwaan; Daniel H. Fulkerson; Mahmud Zamlut; Rashid Khan; Mark M. Walsh

doi:10.12659/AJCR.931080

01 April 2021 : Case report USA

Thromboelastography-Guided Anticoagulant Therapy for the Double Hazard of Thrombohemorrhagic Events in COVID-19: A Report of 3 Cases

Unusual clinical course, Unusual or unexpected effect of treatment

Connor M. Bunch^1ABDEF, Anthony V. Thomas

^12BDEF, John E. Stillson^1ABDEF, Laura Gillespie^3ABD, Kevin P. Lin^1DEF, Jacob Speybroeck^1AD, Hau C. Kwaan^4DEF, Daniel H. Fulkerson^5DEF, Mahmud Zamlut^6BDEF, Rashid Khan^7ABDE, Mark M. Walsh^12ABDEFG*

DOI: 10.12659/AJCR.931080

Am J Case Rep 2021; 22:e931080

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 1. Patient demographics for the 3 cases.

	Patient 1	Patient 2	Patient 3
Demographics
Age (years)	72	55	43
Sex	Female	Female	Female
BMI (kg/m)	32.3	40.6	37.0
Comorbidities
Type II diabetes mellitus	Yes	Yes	No
Hypertension	No	Yes	No
Cardiovascular disease	No	No	No
Chronic renal failure	Yes	No	No
Immunosuppression	No	No	No
BMI – body mass index.

Back to the Article

Thromboelastography-Guided Anticoagulant Therapy for the Double Hazard of Thrombohemorrhagic Events in COVID-19: A Report of 3 Cases

Your Privacy